4:45 PM
 | 
Feb 03, 2010
 |  BC Extra  |  Company News

Acorda sets Ampyra price

Acorda Therapeutics Inc. (NASDAQ:ACOR) said the wholesale acquisition cost of Ampyra dalfampridine (formerly Fampridine-SR) will be $1,056...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >